Agent Capital is a healthcare investment firm focused on novel technologies and therapeutics that address unmet patient need. Our investment areas of focus are new products and technologies for oncology, immunology, neurology and rare disease indications. We make direct equity investments across all stages of development and types of financing rounds.
Location: United States, Massachusetts, Waltham
Employees: 1-10
Founded date: 2016
Investment Type: Venture Capital
Portfolio 19
| Date | Name | Website | Total Raised | Location |
| 27.04.2023 | Foresight ... | foresight-dx.com | $132.75M | United Sta... |
| 22.06.2022 | Carbon Bio... | carbonbio.com | $38M | United Sta... |
| - | Orbus Ther... | orbustherapeutics.com | $103.5M | Canada |
| - | Interius | interiusbio.com | $76M | United Sta... |
| - | Freenome | freenome.com | $1.05B | United Sta... |
| - | Carisma Th... | carismatx.com | $159M | United Sta... |
| - | Precision ... | precisionbiosciences.com | $135.6M | United Sta... |
| - | Pliant The... | pliantrx.com | $207M | United Sta... |
| - | Orchard Th... | orchard-tx.com | $706M | United Kin... |
| - | Aptinyx In... | aptinyx.com | $135M | United Sta... |
Show more
Mentions in press and media 7
| Date | Title | Description |
| 03.02.2025 | Hone Health: $33 Million (Series A) Raised And ivee Acquisition | Hone Health, a leading telehealth clinic specializing in preventative and proactive longevity care, announced that it crossed 300,000 patients tested, 55,000 patients treated, and completed a $33 million Series A funding round with particip... |
| 31.01.2025 | Hone Health Raises $33M to Make Aging Optional | In an era where chronic diseases increasingly impact quality of life, the healthcare system continues to focus on reactive treatment rather than prevention. Many individuals in their mid-30s and beyond experience symptoms like weight gain, ... |
| 29.01.2025 | SafelyYou secures $43M for AI-assisted senior living and more funding news | Photo: Halfpoint Images/Getty Images SafelyYou, maker of AI-enabled technology for fall detection and prevention, closed a $43 million Series C funding round led by Touring Capital, bringing its total raise to more than $100 million. Samsun... |
| 23.11.2024 | TRexBio: $84 Million (Series B) Closed To Decode Human Tissue Immune Biology | TRex Bio – a biotechnology company decoding human tissue immune biology to create revolutionary therapeutics – announced the closing of an oversubscribed $84 million Series B funding round. This funding was led by Delos Capital, with additi... |
| 25.04.2024 | Cerevance Secures $47M to Drive Innovation in CNS Therapeutics | Cerevance, a Boston-based company specializing in precision treatments for central nervous system (CNS) disorders, recently closed a $47 million Series B-1 Extension financing round. The funding, led by Agent Capital, Bioluminescence Ventur... |
| 25.04.2024 | Cerevance Raises $47M in Series B-1 Extension | Cerevance, a Boston, MA-based company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, raised $47M in Series B-1 Extension. The round was led by Agent Capital, Bioluminescence Ventures, and Doubl... |
| 12.10.2021 | Augmented reality startup Magic Leap gets a reset with new funding | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Magic Leap began its life in 2011 as a mysterious augmented reality startup from Florida that man... |